greeksoup/ stock research
Stock research / United States / TEVA / Planned sales

Teva Pharmaceutical Industries Ltd. planned insider sales

In the last twelve months insiders at Teva Pharmaceutical Industries Ltd. filed 42 Form 144 notices of planned sales, 3.6 million shares worth $109.1 million at the time of filing, from 14 sellers. The latest, filed 10 November 2026: Francis Richard D. (officer), 250,000 shares worth $10.7 million, planned for around 10 November 2026 through Societe Generale Private Banking (Monaco). One notice's value as filed does not match the share price that day; it is marked in the table.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
10 November 2026Francis Richard D.Officer250,000$10.7 million10 November 2026None on Form 4 yetSociete Generale Private Banking (Monaco)Vesting of restricted share unitsForm 144
9 November 2026Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL25,000$1.1 million9 November 2026None on Form 4 yetCITIGROUP GLOBAL MARKETS INCSTOCK OPTION EXERCISE AND SALEForm 144
5 November 2026Sabag MarkOfficer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL46,000$1.9 million5 November 202646,000 shares from 5 November 2026CITIGROUP GLOBAL MARKETS INCSTOCK OPTION EXERCISE AND SALEForm 144
4 November 2026Bergwerk DovSenior VP General Counsel Corporate Secretary26,260$1.1 million4 November 202626,260 shares from 4 November 2026Citigroup Global Markets, IncSTOCK OPTION EXERCISE AND SALEForm 144
21 September 2026Savage BrianOfficer, CHIEF LEGAL OFFICER7,028$273,06218 September 2026None on Form 4 yetCITIGROUP GLOBAL MARKETSCASHLESS OPTION EXERCISE AND SALE; SHARES FROM ROLLOVERForm 144
18 September 2026Bridger Management, LLC (1)Shareholder367,600$14.4 million18 September 2026None on Form 4 yetApex Clearing CorporationSee Remark 2Form 144
17 August 2026Lippman EvanOfficer, EVP BUSINESS DEVELOPMENT18,600$680,29117 August 202618,600 shares from 17 August 2026CITIGROUP GLOBAL MARKETSShares from Rollover, ADRForm 144
3 August 2026Jover PlacidExecutive VP, Chief HR Officer12,827$447,3513 August 202612,827 shares from 3 August 2026Citigroup Global Markets, IncRestricted Share Unit Award VestingForm 144
3 August 2026Hughes Eric AExecutive VP Global R&D and Chief Med Officer25,578$892,0513 August 202625,578 shares from 3 August 2026Citigroup Global Markets, IncRestricted Share Unit Award VestingForm 144
18 June 2026Shields MatthewOfficer, EXECUTIVE VP TEVA GLOBAL OPERATIONS9,989$321,54718 June 20269,989 shares from 18 June 2026CITIGROUP GLOBAL MARKETSSHARES FROM ROLLOVERForm 144
11 June 2026Kalif Eliyahu SharonOfficer, EVP CHIEF FINANCIAL OFFICER106,563$3.6 million11 June 2026106,563 shares from 11 June 2026CITIGROUP GLOBAL MARKETSSHARES FROM ROLLOVERForm 144
5 June 2026Francis Richard DOfficer, PRESIDENT AND CEO6,153$211,3565 June 20266,153 shares from 5 June 2026CITIGROUP GLOBAL MARKETS INCRESTRICTED SHARE UNIT AWARD VESTINGForm 144
3 June 2026Shields MatthewOfficer, EXECUTIVE VP TEVA GLOBAL OPERATIONS16,195$532,3303 June 202616,195 shares from 3 June 2026CITIGROUP GLOBAL MARKETSRESTRICTED SHARE UNIT AWARD VESTINGForm 144
14 May 2026Lippman EvanOfficer, EXECUTIVE VP BUSINESS DEVELOPMENT41,658$1.5 million14 May 202641,658 shares from 14 May 2026CITIGROUP GLOBAL MARKETSRESTRICTED SHARE UNIT AWARD VESTINGForm 144
14 May 2026Kalif Eliyahu SharonOfficer, EVP CHIEF FINANCIAL OFFICER153,251$5.5 million14 May 2026153,251 shares from 14 May 2026CITIGROUP GLOBAL MARKETSSHARES FROM ROLLOVERForm 144
5 May 2026Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL30,000$1.1 million5 May 202630,000 shares from 5 May 2026CITIGROUP GLOBAL MARKETS INCSHARES FROM ROLLOVERForm 144
4 May 2026Sabag MarkOfficer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL144,180$5.0 million1 May 2026No matching Form 4 saleCITIGROUP GLOBAL MARKETS INCSHARES FROM ROLLOVERForm 144
30 April 2026Christine FoxOfficer21,258$750,63330 April 202621,258 shares from 30 April 2026Merrill LynchVesting of a Stock AwardForm 144
17 March 2026Sabag MarkOfficer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL62,102$1.9 million17 March 2026206,282 shares from 17 March 2026CITIGROUP GLOBAL MARKETS INCSHARES FROM ROLLOVERForm 144
5 March 2026Savage BrianOfficer, INTERIM CHIEF LEGAL OFFICER1,127$35,6905 March 20263,802 shares from 4 March 2026CITIGROUP GLOBAL MARKETSRESTRICTED SHARE UNIT AWARD VESTINGForm 144
5 March 2026Fox ChristineOfficer, EVP HEAD OF US COMMERCIAL7,924$250,9405 March 202617,022 shares from 4 March 2026CITIGROUP GLOBAL MARKETS INCRESTRICTED SHARE UNIT AWARD VESTING EMForm 144
5 March 2026Hughes Eric AOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER9,533$301,8955 March 202620,810 shares from 4 March 2026CITIGROUP GLOBAL MARKETSRESTRICTED SHARE UNIT AWARD VESTING EMForm 144
5 March 2026Jover PlacidOfficer, EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER14,150$448,1085 March 202614,150 shares from 5 March 2026CITIGROUP GLOBAL MARKETSRESTRICTED SHARE UNIT AWARD VESTINGForm 144
5 March 2026Shields MatthewOfficer, EXECUTIVE VP TEVA GLOBAL OPERATIONS17,295$547,7055 March 202617,295 shares from 5 March 2026CITIGROUP GLOBAL MARKETSRESTRICTED SHARE UNIT AWARD VESTINGForm 144
5 March 2026Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL17,295$547,7055 March 2026108,640 shares from 4 March 2026CITIGROUP GLOBAL MARKETS INCRESTRICTED SHARE AWARD EMForm 144
5 March 2026Francis Richard DOfficer, PRESIDENT AND CEO20,025$634,1605 March 202643,418 shares from 4 March 2026CITIGROUP GLOBAL MARKETS INCRESTRICTED SHARE UNIT AWARD VESTINGForm 144
4 March 2026Fox ChristineOfficer, EVP HEAD OF US COMMERCIAL9,908$321,6584 March 2026No matching Form 4 saleCITIGROUP GLOBAL MARKETS INCRESTRICTED SHARE UNIT AWARD VESTING EMForm 144
4 March 2026Hughes Eric AOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER11,277$366,1024 March 202680,762 shares from 3 March 2026CITIGROUP GLOBAL MARKETSRESTRICTED SHARE UNIT AWARD VESTING EMForm 144
4 March 2026Francis Richard DOfficer, PRESIDENT AND CEO23,393$759,4424 March 2026442,935 shares from 3 March 2026CITIGROUP GLOBAL MARKETS INCRESTRICTED SHARE UNIT AWARD VESTINGForm 144
4 March 2026Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL91,345$3.0 million4 March 2026128,985 shares from 3 March 2026CITIGROUP GLOBAL MARKETS INCRESTRICTED SHARE AWARD; SHARES FROM ROLLOVERForm 144
3 March 2026Savage BrianOfficer, EXECUTIVE VP INTERIM CHIEF LEGAL OFFICER1,274$41,2273 March 20261,274 shares from 3 March 2026CITIGROUP GLOBAL MARKETSRESTRICTED SHARE UNIT AWARD VESTINGForm 144
3 March 2026Hughes Eric AOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER80,762$2.6 million3 March 2026No matching Form 4 saleCITIGROUP GLOBAL MARKETSPERFORMANCE SHARE UNIT AWARD VESTING EM; RESTRICTED SHARE UNIT AWARD VESTING EMForm 144
3 March 2026Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL128,985$4.2 million3 March 2026No matching Form 4 saleCITIGROUP GLOBAL MARKETS INCPERFORMANCE SHARE UNIT AWARD VESTING; RESTRICTED SHARE UNIT AWARD VESTING EM; RESTRICTED SHARE UNIT AWARD VESTING EM RETENTIONForm 144
3 March 2026Francis Richard DOfficer, PRESIDENT AND CEO442,935$14.3 million3 March 2026No matching Form 4 saleCITIGROUP GLOBAL MARKETS INCPERFORMANCE SHARE UNIT AWARD VESTING; RESTRICTED SHARE UNIT AWARD VESTINGForm 144
26 February 2026Kalif Eliyahu SharonOfficer, EVP CHIEF FINANCIAL OFFICER345,810$11.6 million26 February 2026345,810 shares from 26 February 2026CITIGROUP GLOBAL MARKETSSHARES FROM ROLLOVERForm 144
18 February 2026Francis Richard DOfficer, PRESIDENT AND CEO447,778$447,778
value as filed; does not match the share price that day		17 February 2026No matching Form 4 saleCITIGROUP GLOBAL MARKETS INCPERFORMANCE SHARE UNIT AWARD; RESTRICTED SHARE UNIT AWARDForm 144
12 December 2025Bridger Management, LLC (1)Shareholder150,000$4.5 million12 December 2025No matching Form 4 salePiper Sandler & Co.See Remark 2Form 144
9 December 2025Daniell RichardOfficer, EXECUTIVE VP EUROPEAN COMMERCIAL115,468$3.3 million9 December 2025115,468 shares from 9 December 2025CITIGROUP GLOBAL MARKETS INCCASHLESS EXERCISE STOCK OPTIONSForm 144
9 December 2025Sabag MarkOfficer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL216,892$6.2 million9 December 2025216,892 shares from 9 December 2025CITIGROUP GLOBAL MARKETS INCCASHLESS EXERCISE STOCK OPTIONS; SHARES FROM ROLLOVERForm 144
26 November 2025Bridger Management, LLC (1)Shareholder50,000$1.2 million26 November 2025No matching Form 4 salePiper Sandler & Co.See Remark 2Form 144
20 November 2025Fox ChristineOfficer, EVP HEAD OF US COMMERCIAL28,229$699,52320 November 202528,229 shares from 20 November 2025CITIGROUP GLOBAL MARKETS INCRestricted Stock VestingForm 144
14 November 2025Fox ChristineOfficer, EVP HEAD OF US COMMERCIAL30,000$753,32114 November 202530,000 shares from 14 November 2025CITIGROUP GLOBAL MARKETS INCSHARES FROM ROLLOVERForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?